These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7698381)

  • 1. Suppressed mixed lymphocyte reaction in couples with intrauterine growth retardation pregnancies.
    Tsushima R; Fujii T; Nakamura A; Okai T; Juji T; Taketani Y
    Int J Gynaecol Obstet; 1995 Jan; 48(1):37-42. PubMed ID: 7698381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leucocyte antigens and mixed lymphocyte reaction in severe pre-eclampsia.
    Jenkins DM; Need JA; Scott JS; Morris H; Pepper M
    Br Med J; 1978 Mar; 1(6112):542-4. PubMed ID: 147119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histocompatibility antigens and intrauterine fetal growth retardation.
    Weir PE; Oats JN; Holdsworth R; Cross R
    Aust N Z J Obstet Gynaecol; 1985 May; 25(2):108-10. PubMed ID: 3863585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allo-non-specific elevation of maternal killer cell activity in intrauterine growth restriction.
    Fujii T; Tsushima R; Okai T; Shibata Y; Taketani Y
    Int J Gynaecol Obstet; 1996 Mar; 52(3):237-42. PubMed ID: 8775675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction.
    Hung TH; Chen SF; Lo LM; Li MJ; Yeh YL; Hsieh TT
    Placenta; 2012 Apr; 33(4):294-303. PubMed ID: 22264587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal cell-mediated immunity in normal and pre-eclamptic pregnancy.
    Sargent IL; Redman CW; Stirrat GM
    Clin Exp Immunol; 1982 Dec; 50(3):601-9. PubMed ID: 6219835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
    Laskowska M; Laskowska K; Oleszczuk J
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte subpopulations in intrauterine growth retardation in women with or without previous pregnancies.
    Bartha JL; Comino-Delgado R
    Eur J Obstet Gynecol Reprod Biol; 1999 Jan; 82(1):23-7. PubMed ID: 10192480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leucocyte antigens in pregnant women with pre-eclampsia associated with intrauterine growth retardation and in normal controls.
    Omu AE; al-Qattan F; Bukhadour N
    Arch Gynecol Obstet; 1998; 261(3):129-37. PubMed ID: 9651657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does changing paternity contribute to the risk of intrauterine growth retardation?
    Krulewitch CJ; Herman AA; Yu KF; Johnson YR
    Paediatr Perinat Epidemiol; 1997 Jan; 11 Suppl 1():41-7. PubMed ID: 9018714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histocompatibility antigens, mixed lymphocyte reactivity and severe preeclampsia in Israel.
    Persitz E; Oksenberg J; Amar A; Margalioth EJ; Cohen O; Brautbar C
    Gynecol Obstet Invest; 1983; 16(5):283-91. PubMed ID: 6227533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal-fetal histocompatibility in intrauterine growth retarded and normal weight babies.
    Verp MS; Sibul M; Billstrand C; Bellen G; Hsu M; Ober C
    Am J Reprod Immunol; 1993 May; 29(4):195-8. PubMed ID: 8397808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A null mutation in HLA-G is not associated with preeclampsia or intrauterine growth retardation.
    Aldrich C; Verp MS; Walker MA; Ober C
    J Reprod Immunol; 2000 May; 47(1):41-8. PubMed ID: 10779589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal-fetal mixed lymphocyte reactivity in pre-eclampsia.
    Curzen P; Jones E; Gaugas JM
    Br J Exp Pathol; 1977 Oct; 58(5):500-3. PubMed ID: 145232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy outcome in human couples with recurrent spontaneous abortions: HLA antigen profiles; HLA antigen sharing; female serum MLR blocking factors; and paternal leukocyte immunization.
    Beer AE; Semprini AE; Zhu XY; Quebbeman JF
    Exp Clin Immunogenet; 1985; 2(3):137-53. PubMed ID: 2978830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticardiolipin antibodies in pre-eclampsia and intrauterine growth retardation.
    D'Anna R; Scilipoti A; Leonardi J; Scuderi M; Jasonni VM; Leonardi R
    Clin Exp Obstet Gynecol; 1997; 24(3):135-7. PubMed ID: 9478297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Findings and hypotheses in the immunological etiology of gestosis and intrauterine fetal growth retardation].
    Hinney B; Nesselhut T
    Gynakologe; 1990 Jun; 23(3):164-71. PubMed ID: 2201603
    [No Abstract]   [Full Text] [Related]  

  • 18. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy.
    Rizzo R; Andersen AS; Lassen MR; Sørensen HC; Bergholt T; Larsen MH; Melchiorri L; Stignani M; Baricordi OR; Hviid TV
    Am J Reprod Immunol; 2009 Nov; 62(5):320-38. PubMed ID: 19811467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal cell-mediated immunity in pregnancy--lymphocyte responses of mothers and their non-pregnant HLA identical sisters to paternal HLA.
    Moore MP; Sargent IL; Ting A; Redman CW
    Clin Exp Immunol; 1983 Oct; 54(1):91-4. PubMed ID: 6225586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of cytotoxic activity of maternal lymphocytes for the etiology of intrauterine growth retardation].
    Varga P; Scharl A; Szekeres-Bartho J; Bolte A; Szereday Z
    Z Geburtshilfe Perinatol; 1989; 193(4):167-71. PubMed ID: 2800658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.